<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The binding of autoimmune anticardiolipin antibodies to <z:chebi fb="0" ids="16247">phospholipid</z:chebi> has been shown to require a plasma cofactor, beta-2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 (beta2-GPI) </plain></SENT>
<SENT sid="1" pm="."><plain>Antibodies against beta2-GPI are associated with both venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in adults and have been suggested as a new <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> marker </plain></SENT>
<SENT sid="2" pm="."><plain>We present six children with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> at the age of 0-12 months, who had IgG antibodies to beta2-GPI (titers 26, 29, 31, 39, 101 and 109 SGU, when 20 SGU was the cut-off) </plain></SENT>
<SENT sid="3" pm="."><plain>In at least four patients, the conventional antiphospholipid markers (<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and IgG and IgM anticardiolipin) were negative </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> six children had <z:mpath ids='MPATH_458'>normal</z:mpath> results in the other routine <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> assays (thrombin time, antithrombin, protein C, protein S, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, prothrombin mutation) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: the anti-beta-2 glycoprotein 1 assay, requiring only 5 microl serum, may be a useful addition to <z:hpo ids='HP_0003613'>antiphospholipid-antibody</z:hpo> diagnostics in cases of paediatric <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>